ARCHIVES

NIH Signs Agreement For Use Of Five Stem Cell Lines.

This article is from The Cancer Letter archive.

Vol. 27 No. 32 | September 7, 2001

Download PDF Visit The Full Archive

Related Articles

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

OHSU Get $500 Million Pledge; Funds to be Matched in Two Years

September 27, 2013

NCI Could Fund 840 Competing Grants Under Clinton Budget

April 16, 1993

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

Racial Differences In Survival Increase According To Stage

August 31, 2007

BSA Working Group

November 12, 2010